[1]V.M. Corman, D. Muth, D. Niemeyer, C. Drosten, Hosts and Sources of Endemic Human Coronaviruses. Adv Virus Res 100 (2018) 163-188.
[2]C.I. Paules, H.D. Marston, A.S. Fauci, Coronavirus Infections-More Than Just the Common Cold. JAMA (2020).
[3]Y. Zhou, Y. Hou, J. Shen, Y. Huang, W. Martin, F. Cheng, Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery 6 (2020) 14.
[4]H. Zhang, J.M. Penninger, Y. Li, N. Zhong, A.S. Slutsky, Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine 46 (2020) 586-590.
[5]N. Vankadari, Structural interactions between pandemic SARS-CoV-2 spike glycoprotein and human Furin protease. bioRxiv (2020) 2020.2004.2010.036533.
[6]Z.-W. Ye, S. Yuan, K.-S. Yuen, S.-Y. Fung, C.-P. Chan, D.-Y. Jin, Zoonotic origins of human coronaviruses. International journal of biological sciences 16 (2020) 1686-1697.
[7]C. Salata, A. Calistri, C. Parolin, G. Palù, Coronaviruses: a paradigm of new emerging zoonotic diseases. Pathogens and Disease 77 (2020).
[8]C. Wu, Y. Liu, Y. Yang, P. Zhang, W. Zhong, Y. Wang, Q. Wang, Y. Xu, M. Li, X. Li, M. Zheng, L. Chen, H. Li, Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B (2020).
[9]R. Arora, R. Chawla, R. Marwah, P. Arora, R.K. Sharma, V. Kaushik, R. Goel, A. Kaur, M. Silambarasan, R.P. Tripathi, J.R. Bhardwaj, Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud. Evid Based Complement Alternat Med 2011 (2011) 586506.
[10]A. Saini, Physicians of ancient India. J Family Med Prim Care 5 (2016) 254-258.
[11]L. Alleva, C. Charles, I.A. Clark, Using complementary and alternative medicines to target the host response during severe influenza. Evidence-Based Complementary and Alternative Medicine. 7 (2010) 501–510.
[12]M.N. Asl, H. Hosseinzadeh, Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22 (2008) 709-724.
[13]R. Yang, B.C. Yuan, Y.S. Ma, S. Zhou, Y. Liu, The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol 55 (2017) 5-18.
[14]X. Yu, Y. Bao, X. Meng, S. Wang, T. Li, X. Chang, W. Xu, G. Yang, T. Bo, Multi-pathway integrated adjustment mechanism of licorice flavonoids presenting anti-inflammatory activity. Oncol Lett 18 (2019) 4956-4963.
[15]S.H. Kim, J.H. Hong, W.K. Yang, J.H. Geum, H.R. Kim, S.Y. Choi, Y.M. Kang, H.J. An, Y.C. Lee, Herbal Combinational Medication of Glycyrrhiza glabra, Agastache rugosa Containing Glycyrrhizic Acid, Tilianin Inhibits Neutrophilic Lung Inflammation by Affecting CXCL2, Interleukin-17/STAT3 Signal Pathways in a Murine Model of COPD. Nutrients 12 (2020).
[16]Y. Gao, X. Lv, H. Yang, L. Peng, X. Ci, Isoliquiritigenin exerts antioxidative and anti-inflammatory effects via activating the KEAP-1/Nrf2 pathway and inhibiting the NF-kappaB and NLRP3 pathways in carrageenan-induced pleurisy. Food Funct 11 (2020) 2522-2534.
[17]D. Das, S.K. Agarwal, H.M. Chandola, Protective effect of Yashtimadhu (Glycyrrhiza glabra) against side effects of radiation/chemotherapy in head and neck malignancies. Ayu 32 (2011) 196-199.
[18]G. Hoever, L. Baltina, M. Michaelis, R. Kondratenko, G.A. Tolstikov, H.W. Doerr, J. Cinatl, Jr., Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem 48 (2005) 1256-1259.
[19]J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, H.W. Doerr, Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361 (2003) 2045-2046.
[20]E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, T.E. Ferrin, UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25 (2004) 1605-1612.
[21]S. Dallakyan, A.J. Olson, Small-molecule library screening by docking with PyRx. Methods Mol Biol 1263 (2015) 243-250.
[22]D.E.V. Pires, T.L. Blundell, D.B. Ascher, pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. Journal of Medicinal Chemistry 58 (2015) 4066-4072.
[23]Alamgeer., W. Younis, H. Asif, A. Sharif, H. Riaz, I. Bukhari, A. Assiri, Traditional medicinal plants used for respiratory disorders in Pakistan: a review of the ethno-medicinal and pharmacological evidence. . Chin Med 13 (2018).
[24]G. Pinn, Herbal therapy in respiratory disease. Aust Fam Physician 30 (2001) 775-779.
[25]F.P. Santana, N.M. Pinheiro, M.I. Mernak, R.F. Righetti, M.A. Martins, J.H. Lago, F.D. Lopes, I.F. Tiberio, C.M. Prado, Evidences of Herbal Medicine-Derived Natural Products Effects in Inflammatory Lung Diseases. Mediators Inflamm 2016 (2016) 2348968.
[26]R.F. Weiss, V. Fintelmann, Herbal medicine., Stuttgart ; New York : Thieme, 2000.
[27]H.R. Vasanthi, R.P. Parameswari, Indian spices for healthy heart - an overview. Curr Cardiol Rev 6 (2010) 274-279.
[28]A. Sachan, S. Kumar, K. Kumari, D. Singh, Medicinal uses of spices used in our traditional culture: World wide. Journal of Medicinal Plants Studies 6 (2018) 116-122.
[29]M. Dharmendra, S. Deepak, Evaluation of Traditional Ayurvedic Preparation for Prevention and Management of the Novel Coronavirus (SARS-CoV-2) Using Molecular Docking Approach. (2020).
[30]G. Pastorino, L. Cornara, S. Soares, F. Rodrigues, M. Oliveira, Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother Res 32 (2018) 2323-2339.
[31]G. El-Saber Batiha, A. Magdy Beshbishy, A. El-Mleeh, M.M. Abdel-Daim, H. Prasad Devkota, Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae). Biomolecules 10 (2020).
[32]M. Sabouri Ghannad, A. Mohammadi, S. Safiallahy, J. Faradmal, M. Azizi, Z. Ahmadvand, The Effect of Aqueous Extract of Glycyrrhiza glabra on Herpes Simplex Virus 1. Jundishapur J Microbiol 7 (2014) e11616.
[33]K. Fukuchi, N. Okudaira, K. Adachi, R. Odai-Ide, S. Watanabe, H. Ohno, M. Yamamoto, T. Kanamoto, S. Terakubo, H. Nakashima, Y. Uesawa, H. Kagaya, H. Sakagami, Antiviral and Antitumor Activity of Licorice Root Extracts. In Vivo 30 (2016) 777-785.
[34]A. Ashraf, M.M. Ashraf, A. Rafiqe, B. Aslam, S. Galani, S. Zafar, F. Asad, R.D. Asghar, S. Akram, H. Ahmed, S.M.A. Shah, R. Asif, In vivo antiviral potential of Glycyrrhiza glabra extract against Newcastle disease virus. Pak J Pharm Sci 30 (2017) 567-572.
[35]J.Y. Pu, L. He, S.Y. Wu, P. Zhang, X. Huang, [Anti-virus research of triterpenoids in licorice]. Bing Du Xue Bao 29 (2013) 673-679.
[36]H.A. Lindner, N. Fotouhi-Ardakani, V. Lytvyn, P. Lachance, T. Sulea, R. Menard, The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J Virol 79 (2005) 15199-15208.
[37]S. Jo, S. Kim, D.H. Shin, M.S. Kim, Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem 35 (2020) 145-151.
[38]F. Li, Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol 3 (2016) 237-261.
[39]Q. Wang, Y. Zhang, L. Wu, S. Niu, C. Song, Z. Zhang, G. Lu, C. Qiao, Y. Hu, K.-Y. Yuen, Q. Wang, H. Zhou, J. Yan, J. Qi, Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell (2020).
[40]Y. Yuan, D. Cao, Y. Zhang, J. Ma, J. Qi, Q. Wang, G. Lu, Y. Wu, J. Yan, Y. Shi, X. Zhang, G.F. Gao, Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun 8 (2017) 15092.
[41]C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang, B. Cao, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020) 497-506.